In this video interview, Marc Buyse, ScD, founder and CEO of IDDI, examines the most common threats to trial data reliability, including opaque methodologies, synthetic controls, and the limits of ...

Risk-bearing provider organizations rely on physicians to achieve cost savings. The literature on physician-mediated interventions to reduce costs is scant and provides little guidance on effective ...

A web-based tool that incorporates patient preference in antidepressant selection was associated with a significant decrease ...

A 5-day amoxicillin challenge was feasible for evaluating delayed penicillin allergy, with more than 80% of participants completing the protocol; immune‑mediated reactions were uncommon but occurred ...

If you've ever considered including a multivitamin in your daily regimen, now might be the perfect time to start.

Company is well positioned following positive FDA Type B meeting outcome, fully enrolled Phase 2 trial for its lead clinical program, and recent $5 million public offering, as commercial operation ...

PRAME Cell Therapy: Global, randomized, controlled Phase 3 trial, SUPRAME, in previously treated advanced melanoma ongoing; anzu-cel received Orphan Drug Designation from the FDA for the treatment of ...

Software developers who spent years mastering their craft are now watching AI coding assistants rewrite the rules of their profession, and the evidence on whether those tools actually help is far from ...

Profound Medical Corp. (NASDAQ:PROF) Q4 2025 Earnings Call Transcript March 6, 2026 Operator: Good day, and thank you for ...

Daily intake of avocado and mango may improve endothelial function in people with prediabetes, according to new data ...

A closer look at a recent study reveals that vegans have significantly lower inflammatory markers than vegetarians and meat eaters ...

Physical exertion combined with deep concentration can severely slow down human reaction times. A recent trial reveals that ...